Rheumatology
1051 – 1060 of 1579
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor alpha Therapies Does the Risk Change With the Time Since Start of Treatment?
(
- Contribution to journal › Article
-
Mark
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype
(
- Contribution to journal › Article
-
Mark
The tyrosine sulfate rich domains of the LRR-proteins fibromodulin and osteoadherin bind motifs of basic clusters in a variety of heparin binding proteins including bioactive factors.
(
- Contribution to journal › Article
-
Mark
Differences in Longitudinal Disease and Treatment Characteristics of Patients with Rheumatoid Arthritis Replying and Not Replying to a Postal Questionnaire. Experience from a Biologics Register in Southern Sweden.
(
- Contribution to journal › Article
-
Mark
Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation.
(
- Contribution to journal › Article
-
Mark
Mitochondrial DNA polymorphisms are associated with susceptibility and phenotype of systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.
(
- Contribution to journal › Article
-
Mark
Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement system.
(
- Contribution to journal › Article
-
Mark
Complement inhibitor C4b-binding protein interacts directly with small glycoproteins of the extracellular matrix.
(
- Contribution to journal › Article
-
Mark
Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.
(
- Contribution to journal › Article